1. NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer. V4.2017. https://www.nccn.org/professionals/physician_gls/PDF/bladder.pdf.
2. Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up;Bellmunt;Ann Oncol,2014
3. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Loehrer;J Clin Oncol,1992
4. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005
5. SEER Cancer Stat Facts: Bladder Cancer; 2017. http://seer.cancer.gov/statfacts/html/urinb.html.